TY - JOUR
T1 - Petrolatum
T2 - Barrier repair and antimicrobial responses underlying this "inert" moisturizer
AU - Czarnowicki, Tali
AU - Malajian, Dana
AU - Khattri, Saakshi
AU - Correa da Rosa, Joel
AU - Dutt, Riana
AU - Finney, Robert
AU - Dhingra, Nikhil
AU - Xiangyu, Peng
AU - Xu, Hui
AU - Estrada, Yeriel D.
AU - Zheng, Xiuzhong
AU - Gilleaudeau, Patricia
AU - Sullivan-Whalen, Mary
AU - Suaréz-Fariñas, Mayte
AU - Shemer, Avner
AU - Krueger, James G.
AU - Guttman-Yassky, Emma
N1 - Publisher Copyright:
© 2016 American Academy of Allergy, Asthma & Immunology.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Background Petrolatum is a common moisturizer often used in the prevention of skin infections after ambulatory surgeries and as a maintenance therapy of atopic dermatitis (AD). However, the molecular responses induced by petrolatum in the skin have never been assessed. Objective We sought to define the cutaneous molecular and structural effects induced by petrolatum. Methods Thirty-six healthy subjects and 13 patients with moderate AD (mean SCORAD score, 39) were studied by using RT-PCR, gene arrays, immunohistochemistry, and immunofluorescence performed on control skin, petrolatum-occluded skin, and skin occluded with a Finn chamber only. Results Significant upregulations of antimicrobial peptides (S100A8/fold change [FCH], 13.04; S100A9/FCH, 11.28; CCL20/FCH, 8.36; PI3 [elafin]/FCH, 15.40; lipocalin 2/FCH, 6.94, human β-defensin 2 [DEFB4A]/FCH, 4.96; P <.001 for all) and innate immune genes (IL6, IL8, and IL1B; P <.01) were observed in petrolatum-occluded skin compared with expression in both control and occluded-only skin. Application of petrolatum also induced expression of key barrier differentiation markers (filaggrin and loricrin), increased stratum corneum thickness, and significantly reduced T-cell infiltrates in the setting of "normal-appearing" or nonlesional AD skin, which is known to harbor barrier and immune defects. Conclusions Petrolatum robustly modulates antimicrobials and epidermal differentiation barrier measures. These data shed light on the beneficial molecular responses of petrolatum in barrier-defective states, such as AD and postoperative wound care.
AB - Background Petrolatum is a common moisturizer often used in the prevention of skin infections after ambulatory surgeries and as a maintenance therapy of atopic dermatitis (AD). However, the molecular responses induced by petrolatum in the skin have never been assessed. Objective We sought to define the cutaneous molecular and structural effects induced by petrolatum. Methods Thirty-six healthy subjects and 13 patients with moderate AD (mean SCORAD score, 39) were studied by using RT-PCR, gene arrays, immunohistochemistry, and immunofluorescence performed on control skin, petrolatum-occluded skin, and skin occluded with a Finn chamber only. Results Significant upregulations of antimicrobial peptides (S100A8/fold change [FCH], 13.04; S100A9/FCH, 11.28; CCL20/FCH, 8.36; PI3 [elafin]/FCH, 15.40; lipocalin 2/FCH, 6.94, human β-defensin 2 [DEFB4A]/FCH, 4.96; P <.001 for all) and innate immune genes (IL6, IL8, and IL1B; P <.01) were observed in petrolatum-occluded skin compared with expression in both control and occluded-only skin. Application of petrolatum also induced expression of key barrier differentiation markers (filaggrin and loricrin), increased stratum corneum thickness, and significantly reduced T-cell infiltrates in the setting of "normal-appearing" or nonlesional AD skin, which is known to harbor barrier and immune defects. Conclusions Petrolatum robustly modulates antimicrobials and epidermal differentiation barrier measures. These data shed light on the beneficial molecular responses of petrolatum in barrier-defective states, such as AD and postoperative wound care.
KW - antimicrobial peptides
KW - atopic dermatitis
KW - barrier
KW - innate immunity
KW - moisturizer
KW - occlusion
KW - patch tests
KW - Petrolatum
KW - skin surgeries
UR - http://www.scopus.com/inward/record.url?scp=84945561210&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2015.08.013
DO - 10.1016/j.jaci.2015.08.013
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26431582
AN - SCOPUS:84945561210
VL - 137
SP - 1091-1102.e7
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 4
ER -